Filing Flows › Aurinia Pharmaceuticals (AUPH) › Net product sales revenue
Aurinia Pharmaceuticals (AUPH) Net product sales revenue by quarter
Aurinia Pharmaceuticals' Net product sales revenue was $79.4M in Q3 2026 (third quarter 2026), 0% from Q2 2026. Over the last 7 quarters it ranged from $60.0M (Q1 2025) to $79.4M (Q3 2026).
| Quarter | Net product sales revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $79.4M | 0% | +12% |
| Q2 2026 | $79.4M | +8% | +19% |
| Q1 2026 | $73.6M | -0.8% | +23% |
| Q4 2025 | $74.2M | +5% | — |
| Q3 2025 | $70.6M | +6% | — |
| Q2 2025 | $66.6M | +11% | — |
| Q1 2025 | $60.0M | — | — |
Q3 2026 at a glance
Aurinia Pharmaceuticals, Q3 2026: revenue $83.7M (+14% year over year), operating margin 42.3%, net earnings $31.7M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Aurinia Pharmaceuticals' Net product sales revenue?
Aurinia Pharmaceuticals' Net product sales revenue was $79.4M in Q3 2026 (third quarter 2026), 0% from Q2 2026.
How has Aurinia Pharmaceuticals' Net product sales revenue changed?
Over the last 7 quarters it ranged from $60.0M (Q1 2025) to $79.4M (Q3 2026).
Q3 2026 results → · How Aurinia Pharmaceuticals makes money →